Literature DB >> 34905618

Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.

Woosuk S Hur1,2,3, David S Paul3,4, Emma G Bouck1,3, Oscar A Negrón1,2,3, Jean-Marie Mwiza3,4, Lauren G Poole5, Holly M Cline-Fedewa5, Emily G Clark3,4, Lih Jiin Juang6, Jerry Leung6, Christian J Kastrup6,7, Tatiana P Ugarova8, Alisa S Wolberg1,3, James P Luyendyk5, Wolfgang Bergmeier3,4, Matthew J Flick1,2,3.   

Abstract

Genetic variants within the fibrinogen Aα chain encoding the αC-region commonly result in hypodysfibrinogenemia in patients. However, the (patho)physiological consequences and underlying mechanisms of such mutations remain undefined. Here, we generated Fga270 mice carrying a premature termination codon within the Fga gene at residue 271. The Fga270 mutation was compatible with Mendelian inheritance for offspring of heterozygous crosses. Adult Fga270/270 mice were hypofibrinogenemic with ∼10% plasma fibrinogen levels relative to FgaWT/WT mice, linked to 90% reduction in hepatic Fga messenger RNA (mRNA) because of nonsense-mediated decay of the mutant mRNA. Fga270/270 mice had preserved hemostatic potential in vitro and in vivo in models of tail bleeding and laser-induced saphenous vein injury, whereas Fga-/- mice had continuous bleeding. Platelets from FgaWT/WT and Fga270/270 mice displayed comparable initial aggregation following adenosine 5'-diphosphate stimulation, but Fga270/270 platelets quickly disaggregated. Despite ∼10% plasma fibrinogen, the fibrinogen level in Fga270/270 platelets was ∼30% of FgaWT/WT platelets with a compensatory increase in fibronectin. Notably, Fga270/270 mice showed complete protection from thrombosis in the inferior vena cava stasis model. In a model of Staphylococcus aureus peritonitis, Fga270/270 mice supported local, fibrinogen-mediated bacterial clearance and host survival comparable to FgaWT/WT, unlike Fga-/- mice. Decreasing the normal fibrinogen levels to ∼10% with small interfering RNA in mice also provided significant protection from venous thrombosis without compromising hemostatic potential and antimicrobial function. These findings both reveal novel molecular mechanisms underpinning fibrinogen αC-region truncation mutations and highlight the concept that selective fibrinogen reduction may be efficacious for limiting thrombosis while preserving hemostatic and immune protective functions.
© 2022 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34905618      PMCID: PMC8900273          DOI: 10.1182/blood.2021012537

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization.

Authors:  V M Homer; J L Mullin; S O Brennan; A Barr; P M George
Journal:  J Thromb Haemost       Date:  2003-06       Impact factor: 5.824

3.  Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X.

Authors:  O V Gorkun; A H Henschen-Edman; L F Ping; S T Lord
Journal:  Biochemistry       Date:  1998-11-03       Impact factor: 3.162

4.  Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage.

Authors:  H J Ridgway; S O Brennan; J M Faed; P M George
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

5.  Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen.

Authors:  Daria Zamolodchikov; Hanna E Berk-Rauch; Deena A Oren; Daniel S Stor; Pradeep K Singh; Masanori Kawasaki; Kazuyoshi Aso; Sidney Strickland; Hyung Jin Ahn
Journal:  Blood       Date:  2016-07-07       Impact factor: 22.113

6.  Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain.

Authors:  Heyu Ni; Jessie M Papalia; Jay L Degen; Denisa D Wagner
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

7.  Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.

Authors:  Joni M Prasad; Oleg V Gorkun; Harini Raghu; Sherry Thornton; Eric S Mullins; Joseph S Palumbo; Ya-Ping Ko; Magnus Höök; Tovo David; Shaun R Coughlin; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

8.  A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.

Authors:  Adam Miszta; Anna K Kopec; Asmita Pant; Lori A Holle; James R Byrnes; Daniel A Lawrence; Kirk C Hansen; Matthew J Flick; James P Luyendyk; Bas de Laat; Alisa S Wolberg
Journal:  Blood       Date:  2020-05-07       Impact factor: 22.113

9.  GPVI (Glycoprotein VI) Interaction With Fibrinogen Is Mediated by Avidity and the Fibrinogen αC-Region.

Authors:  Rui-Gang Xu; Julia S Gauer; Stephen R Baker; Alexandre Slater; Eleyna M Martin; Helen R McPherson; Cédric Duval; Iain W Manfield; Arkadiusz M Bonna; Steve P Watson; Robert A S Ariëns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 8.311

10.  Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency.

Authors:  Amy W Strilchuk; Scott C Meixner; Jerry Leung; Nooshin S Safikhan; Jayesh A Kulkarni; Hannah M Russell; Roy van der Meel; Michael R Sutherland; A Phillip Owens; Joseph S Palumbo; Edward M Conway; Edward L G Pryzdial; Pieter R Cullis; Christian J Kastrup
Journal:  Blood       Date:  2020-12-17       Impact factor: 25.476

View more
  2 in total

Review 1.  Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.

Authors:  Alisa S Wolberg; Yaqiu Sang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-06-02       Impact factor: 10.514

2.  Hyperglycemia may increase deep vein thrombosis in trauma patients with lower limb fracture.

Authors:  Xiaojie Liu; Tiajun Li; Hui Xu; Chunhua Wang; Xiaojun Ma; Hui Huang; Yanling Hu; Haichen Chu
Journal:  Front Cardiovasc Med       Date:  2022-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.